|
1
|
McDermott U, Longley DB and Johnston PG:
Molecular and biochemical markers in colorectal cancer. Ann Oncol.
13(Suppl 4): 235–245. 2002. View Article : Google Scholar
|
|
2
|
Jemal A, Murray T, Ward E, et al: Cancer
statistics, 2005. CA Cancer J Clin. 55:10–30. 2005. View Article : Google Scholar
|
|
3
|
Sporn MB: The war on cancer. Lancet.
347:1377–1381. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Voulgari A and Pintzas A:
Epithelial-mesenchymal transition in cancer metastasis: mechanisms,
markers and strategies to overcome drug resistance in the clinic.
Biochim Biophys Acta. 1796:75–90. 2009.PubMed/NCBI
|
|
5
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: at the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rosivatz E, Becker I, Specht K, et al:
Differential expression of the epithelial-mesenchymal transition
regulators snail, SIP1, and twist in gastric cancer. Am J Pathol.
161:1881–1891. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mani SA, Guo W, Liao MJ, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Roy S and Majumdar AP: Signaling in colon
cancer stem cells. J Mol Signal. 7:112012. View Article : Google Scholar
|
|
11
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cell, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bhat-Nakshatri P, Appaiah H, Ballas C, et
al: SLUG/SNAI2 and tumor necrosis factor generate breast cells with
CD44+/CD24− phenotype. BMC Cancer.
10:4112010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Giannoni E, Bianchini F, Masieri L, et al:
Reciprocal activation of prostate cancer cells and
cancer-associated fibroblasts stimulates epithelial-mesenchymal
transition and cancer stemness. Cancer Res. 70:6945–6956. 2010.
View Article : Google Scholar
|
|
14
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ginestier C, Hur MH, Charafe-Jauffret E,
et al: ALDH1 is a marker of normal and malignant human mammary stem
cells and a predictor of poor clinical outcome. Cell Stem Cell.
1:555–567. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang EH, Hynes MJ, Zhang T, et al:
Aldehyde dehydrogenase 1 is a marker for normal and malignant human
colonic stem cells (SC) and tracks SC overpopulation during colon
tumorigenesis. Cancer Res. 69:3382–3389. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A III: AJCC Cancer Staging Manual. 7th
edition. Springer; Chicago, IL: 2010
|
|
18
|
Qiao Q, Ramadani M, Gansauge S, Gansauge
F, Leder G and Beger HG: Reduced membranous and ectopic cytoplasmic
expression of β-catenin correlate with cyclin D1 overexpression and
poor prognosis in pancreatic cancer. Int J Cancer. 95:194–197.
2001.
|
|
19
|
Yang MH, Chen CL, Chau GY, et al:
Comprehensive analysis of the independent effect of twist and snail
in promoting metastasis of hepatocellular carcinoma. Hepatology.
50:1464–1474. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schwock J, Bradley G, Ho JC, et al: SNAI1
expression and the mesenchymal phenotype: an immunohistochemical
study performed on 46 cases of oral squamous cell carcinoma. BMC
Clin Pathol. 10:12010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee TK, Poon RT, Yuen AP, et al: Twist
overexpression correlates with hepatocellular carcinoma metastasis
through induction of epithelial-mesenchymal transition. Clin Cancer
Res. 12:5369–5376. 2006. View Article : Google Scholar
|
|
22
|
Valdés-Mora F, Gómez del Pulgar T, Bandrés
E, et al: TWIST1 overexpression is associated with nodal invasion
and male sex in primary colorectal cancer. Ann Surg Oncol.
16:78–87. 2009.PubMed/NCBI
|
|
23
|
Gomez I, Peña C, Herrera M, et al:
TWIST1 is expressed in colorectal carcinomas and predicts
patient survival. PLoS One. 6:e180232011. View Article : Google Scholar
|
|
24
|
Natalwala A, Spychal R and Tselepis C:
Epithelial-mesenchymal transition mediated tumourigenesis in the
gastrointestinal tract. World J Gastroenterol. 14:3792–3797. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nieto MA: The snail superfamily of
zinc-finger transcription factors. Nat Rev Mol Cell Biol.
3:155–166. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shioiri M, Shida T, Koda K, et al: Slug
expression is an independent prognostic parameter for poor survival
in colorectal carcinoma patients. Br J Cancer. 94:1816–1822. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bolós V, Peinado H, Pérez-Moreno MA, Fraga
MF, Esteller M and Cano A: The transcription factor Slug represses
E-cadherin expression and induces epithelial to mesenchymal
transitions: a comparison with Snail and E47 repressors. J Cell
Sci. 116:499–511. 2003.
|
|
28
|
Fan F, Samuel S, Evans KW, Lu J, Xia L,
Zhou Y, Sceusi E, Tozzi F, Ye XC, Mani SA and Ellis LM:
Overexpression of Snail induces epithelial-mesenchymal transition
and a cancer stem cell-like phenotype in human colorectal cancer
cells. Cancer Med. 1:5–16. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
O’Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110.
2007.PubMed/NCBI
|
|
30
|
Shmelkov SV, Butler JM, Hooper AT, et al:
CD133 expression is not restricted to stem cells, and both
CD133+ and CD133− metastatic colon cancer
cells initiate tumors. J Clin Invest. 118:2111–2120.
2008.PubMed/NCBI
|
|
31
|
Zhou BP, Deng J, Xia W, et al: Dual
regulation of Snail by GSK-3β-mediated phosphorylation in control
of epithelial-mesenchymal transition. Nat Cell Biol. 6:931–940.
2004.PubMed/NCBI
|
|
32
|
Smit MA, Geiger TR, Song JY, Gitelman I
and Peeper DS: A Twist-Snail axis critical for TrkB-induced
epithelial-mesenchymal transition-like transformation, anoikis
resistance, and metastasis. Mol Cell Biol. 29:3722–3737. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang J, Mani SA, Donaher JL, et al: Twist,
a master regulator of morphogenesis, plays an essential role in
tumor metastasis. Cell. 117:927–939. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Imammura T, Hikita A and Inoue Y: The
roles of the TGF-β signaling in carcinogenesis and breast cancer
metastasis. Breast Cancer. 19:118–124. 2012.
|
|
35
|
Huang D and Du X: Crosstalk between tumor
cells and microenviroment via Wnt pathway in colorectal cancer
dissemination. World J Gastroenterol. 14:1823–1827. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kwok WK, Ling MT, Lee TW, et al:
Up-regulation of TWIST in prostate cancer and its implication as a
therapeutic target. Cancer Res. 65:5153–5162. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yu L, Li HZ, Lu SM, et al: Alteration in
TWIST expression: possible role in paclitaxel-induced apoptosis in
human laryngeal carcinoma Hep-2 cell line. Croat Med J. 50:536–542.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yang AD, Fan F, Camp ER, et al: Chronic
oxaliplatin resistance induces epithelial-to-mesenchymal transition
in colorectal cancer cell lines. Clin Cancer Res. 12:4147–4153.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Connolly EC, Freimuth J and Akhurst RJ:
Complexities of TGF-β targeted cancer therapy. Int J Biol Sci.
8:964–978. 2012.
|
